This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovations of Peter Stütz
Introduction
Peter Stütz is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with somatostatin receptors. His work has implications for various therapeutic applications.
Latest Patents
Peter Stütz holds a patent for "Ergoline derivatives and their use as somatostatin receptor antagonists." This invention provides compounds of formula I, which are essential for advancing medical treatments related to somatostatin receptor activity. He has 1 patent to his name.
Career Highlights
Stütz is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to engage in cutting-edge research and development, contributing to the advancement of medical science.
Collaborations
Throughout his career, Peter Stütz has collaborated with esteemed colleagues, including Paul Pfaeffli and Peter Neumann. These partnerships have fostered innovation and have been instrumental in the success of his projects.
Conclusion
Peter Stütz exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the realm of somatostatin receptor antagonists, highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile